Literature DB >> 16047032

Risk factors for nosocomial infections in selected neonatal intensive care units in Colombia, South America.

Mario A Rojas1, Meica M Efird, Juan M Lozano, Carl L Bose, María X Rojas, Martín A Rondón, Gloria Ruiz, Juan G Piñeros, Catherine Rojas, Guillermo Robayo, Angela Hoyos, Maria H Gosendi, Hernan Cruz, Michael O'Shea, Angela Leon.   

Abstract

OBJECTIVE: This study was designed to identify risk factors for nosocomial infections among infants admitted into eight neonatal intensive care units in Colombia. Knowledge of modifiable risk factors could be used to guide the design of interventions to prevent the problem. STUDY
DESIGN: Data were collected prospectively from eight neonatal units. Nosocomial infection was defined as culture-proven infection diagnosed after 72 hours of hospitalization, resulting in treatment with antibiotics for >3 days. Associations were expressed as odds ratios. Logistic regression was used to adjust for potential confounders.
RESULTS: From a total of 1504 eligible infants, 80 were treated for 127 episodes of nosocomial infection. Logistic regression analysis identified the combined exposure to postnatal steroids and H2-blockers, and use of oral gastric tubes for enteral nutrition as risk factors significantly associated with nosocomial infection.
CONCLUSION: Nosocomial infections in Colombian neonatal intensive care units were associated with modifiable risk factors including use of postnatal steroids and H2-blockers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047032     DOI: 10.1038/sj.jp.7211353

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  8 in total

1.  Building global health through a center-without-walls: the Vanderbilt Institute for Global Health.

Authors:  Sten H Vermund; Vikrant V Sahasrabuddhe; Sheetal Khedkar; Yujiang Jia; Carol Etherington; Alfredo Vergara
Journal:  Acad Med       Date:  2008-02       Impact factor: 6.893

2.  Cimetidine does not prevent lung injury in newborn premature infants.

Authors:  Robert B Cotton; Tom A Hazinski; Jason D Morrow; L Jackson Roberts; Darryl C Zeldin; Daniel P Lindstrom; Urpo Lappalainen; Amy B Law; Steven Steele
Journal:  Pediatr Res       Date:  2006-04-26       Impact factor: 3.756

3.  Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals.

Authors:  Jonathan L Slaughter; Michael R Stenger; Patricia B Reagan; Sudarshan R Jadcherla
Journal:  J Pediatr       Date:  2016-04-27       Impact factor: 4.406

4.  Nosocomial infections in pediatric population and antibiotic resistance of the causative organisms in north of iran.

Authors:  Salar Behzadnia; Alireza Davoudi; Mohammad Sadegh Rezai; Fatemeh Ahangarkani
Journal:  Iran Red Crescent Med J       Date:  2014-02-05       Impact factor: 0.611

5.  Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: an increasing problem.

Authors:  Johanna M Vanegas; O Lorena Parra; J Natalia Jiménez
Journal:  BMC Infect Dis       Date:  2016-09-01       Impact factor: 3.090

6.  Risk Factors for Health Care-Associated Bloodstream Infections in a Neonatal Intensive Care Unit.

Authors:  Sabahattin Ertugrul; Fesih Aktar; Ilyas Yolbas; Ahmet Yilmaz; Bilal Elbey; Ahmet Yildirim; Kamil Yilmaz; Recep Tekin
Journal:  Iran J Pediatr       Date:  2016-07-27       Impact factor: 0.364

7.  Association between histamine-2 receptor antagonists and adverse outcomes in neonates: A systematic review and meta-analysis.

Authors:  Victor S Santos; Marina S Freire; Ruth N S Santana; Paulo R S Martins-Filho; Luis E Cuevas; Ricardo Q Gurgel
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

8.  Epidemiology of neonatal infections in hospitals of Nepal: evidence from a large- scale study.

Authors:  Shyam Sundar Budhathoki; Avinash K Sunny; Pragya Gautam Paudel; Jeevan Thapa; Lila Bahadur Basnet; Sandeepa Karki; Rejina Gurung; Prajwal Paudel; Ashish Kc
Journal:  Arch Public Health       Date:  2020-05-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.